Metko, M.; Tonne, J.; Veliz Rios, A.; Thompson, J.; Mudrick, H.; Masopust, D.; Diaz, R.M.; Barry, M.A.; Vile, R.G.
Intranasal Prime–Boost with Spike Vectors Generates Antibody and T-Cell Responses at the Site of SARS-CoV-2 Infection. Vaccines 2024, 12, 1191.
https://doi.org/10.3390/vaccines12101191
AMA Style
Metko M, Tonne J, Veliz Rios A, Thompson J, Mudrick H, Masopust D, Diaz RM, Barry MA, Vile RG.
Intranasal Prime–Boost with Spike Vectors Generates Antibody and T-Cell Responses at the Site of SARS-CoV-2 Infection. Vaccines. 2024; 12(10):1191.
https://doi.org/10.3390/vaccines12101191
Chicago/Turabian Style
Metko, Muriel, Jason Tonne, Alexa Veliz Rios, Jill Thompson, Haley Mudrick, David Masopust, Rosa Maria Diaz, Michael A. Barry, and Richard G. Vile.
2024. "Intranasal Prime–Boost with Spike Vectors Generates Antibody and T-Cell Responses at the Site of SARS-CoV-2 Infection" Vaccines 12, no. 10: 1191.
https://doi.org/10.3390/vaccines12101191
APA Style
Metko, M., Tonne, J., Veliz Rios, A., Thompson, J., Mudrick, H., Masopust, D., Diaz, R. M., Barry, M. A., & Vile, R. G.
(2024). Intranasal Prime–Boost with Spike Vectors Generates Antibody and T-Cell Responses at the Site of SARS-CoV-2 Infection. Vaccines, 12(10), 1191.
https://doi.org/10.3390/vaccines12101191
